Atli, AbdullahSelvi, YavuzYildiz, AydinKaya, Mehmet Cemal2020-03-262020-03-2620131017-7833https://dx.doi.org/10.5455/bcp.20130303114826https://hdl.handle.net/20.500.12395/29240Diplopia is a condition that involves seeing double and impairs quality of life. Acute diplopia can be seen with some general medical drugs and psychotropic drugs. Aripiprazole is a new atypical antipsychotic agent; it has partial agonist activity at D2 and 5-HT1A receptors and antagonist activity at 5-HT2A receptors. This paper reports development of diplopia, a rare adverse effect of psychotropic drugs, in a 24 year old patient with schizophreniform disorder following use of oral aripiprazole. Clinicians should keep in mind that diplopia may occur with aripiprazole treatment.en10.5455/bcp.20130303114826info:eu-repo/semantics/closedAccessaripiprazolediplopiaadverse effectArticle234353356N/AWOS:000339983000009Q4